EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Maternal overweight and obesity and its association with metabolic changes and fetal overgrowth in the absence of gestational diabetes mellitus: A prospective cohort study

Cécile Monod iD, Grammata Kotzaeridi, Tina Linder, Gülen Yerlikaya-Schatten, Silke Wegener, Beatrice Mosimann, Wolfgang Henrich, Andrea Tura, Christian S Göbl

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14688 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Cécile Monod und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Diabetes, Gestational, Insulin Resistance. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Previous studies indicated an association between fetal overgrowth and maternal obesity independent of gestational diabetes mellitus (GDM). However, the underlying mechanisms beyond this possible association are not completely understood. This study investigates metabolic changes and their association with fetal and neonatal biometry in overweight and obese mothers who remained normal glucose‐tolerant during gestation. Material and methods In this prospective cohort study 893 women who did not develop GDM were categorized according to their pregestational body mass index (BMI): 570 were normal weight, 220 overweight and 103 obese. Study participants received a broad metabolic evaluation before 16 weeks and were followed up until delivery to assess glucose levels during the oral glucose tolerance test (OGTT) at mid‐gestation as well as fetal biometry in ultrasound and pregnancy outcome data.

Results

Increased maternal BMI was associated with an adverse metabolic profile at the beginning of pregnancy, including a lower degree of insulin sensitivity (as assessed by the quantitative insulin sensitivity check index) in overweight (mean difference: −2.4, 95% CI −2.9 to −1.9, p < 0.001) and obese (mean difference: −4.3, 95% CI −5.0 to −3.7, p < 0.001) vs normal weight women. Despite not fulfilling diagnosis criteria for GDM, overweight and obese mothers showed higher glucose levels at fasting and during the OGTT. Finally, we observed increased measures of fetal subcutaneous tissue thickness in ultrasound as well as higher proportions of large‐for‐gestational‐age infants in overweight (18.9%, odds ratio [OR] 1.74, 95% CI 1.08–2.78, p = 0.021) and obese mothers (21.0%, OR 1.99, 95% CI 1.06–3.59, p = 0.027) vs normal weight controls (11.8%). The risk for large for gestational age was further determined by OGTT glucose (60 min: OR 1.11, 95% CI 1.02–1.21, p = 0.013; 120 min: OR 1.13, 95% CI 1.02–1.27, P = 0.025, for the increase of 10 mg/dL) and maternal triglyceride concentrations (OR 1.11, 95% CI 1.01–1.22, p = 0.036, for the increase of 20 mg/dL).

Conclusions

Mothers affected by overweight or obesity but not GDM had a higher risk for fetal overgrowth. An impaired metabolic milieu related to increased maternal BMI as well as higher glucose levels at mid‐gestation may impact fetal overgrowth in women still in the range of normal glucose tolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalInsulin ResistanceInfant, NewbornPregnancyFemaleHumansOverweightProspective StudiesFetal MacrosomiaObesityBody Mass IndexGlucose

Stichwörter der Autor:innen

fetal overgrowthfetal subcutaneous tissue thicknesslarge for gestational agematernal obesitynormal glucose tolerance

Substanzen

Glucose

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University Hospital Basel, Basel, Switzerland.
  • Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
  • Clinic of Obstetrics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • CNR Institute of Neuroscience, Padua, Italy.

ORCID-Profile: Cécile Monod

Zitieren

APA

Monod, C., Kotzaeridi, G., Linder, T., Yerlikaya-Schatten, G., Wegener, S., Mosimann, B., Henrich, W., Tura, A., & Göbl, C. S. (2024). Maternal overweight and obesity and its association with metabolic changes and fetal overgrowth in the absence of gestational diabetes mellitus: A prospective cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14688

Vancouver

Monod C, Kotzaeridi G, Linder T, Yerlikaya-Schatten G, Wegener S, Mosimann B, et al. Maternal overweight and obesity and its association with metabolic changes and fetal overgrowth in the absence of gestational diabetes mellitus: A prospective cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14688

BibTeX
@article{Monod2024,
  author = {Monod, Cécile and Kotzaeridi, Grammata and Linder, Tina and Yerlikaya-Schatten, Gülen and Wegener, Silke and Mosimann, Beatrice and Henrich, Wolfgang and Tura, Andrea and Göbl, Christian S},
  title = {Maternal overweight and obesity and its association with metabolic changes and fetal overgrowth in the absence of gestational diabetes mellitus: A prospective cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14688}
}
Kostenlos starten →